---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-168460"
form_type: "8-K"
ticker: "IRON"
cik: "0001816736"
company_name: "Disc Medicine, Inc."
filed_at: "2023-06-16T23:59:59+00:00"
generated_at: "2026-06-13T23:07:34.513607+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Disc Medicine prices upsized $137.2M public offering of common stock and pre-funded warrants

## Summary
- Priced 2,595,919 shares at $49.00 per share and 204,081 pre-funded warrants at $48.9999 each.
- Gross proceeds ~$137.2M before discounts/expenses; net proceeds expected ~$128.2M (~$147.6M if option exercised).
- Underwriters granted 30-day option to purchase up to 420,000 additional shares at offering price less discounts.
- Proceeds to fund research, clinical development, working capital, and general corporate purposes.
- Offering expected to close June 16, 2023; joint book-runners: Morgan Stanley, SVB Securities, Stifel, BMO Capital Markets.

## SEC filing metadata
- accession: 0001193125-23-168460
- form_type: 8-K
- ticker: IRON
- cik: 0001816736
- company_name: Disc Medicine, Inc.
- filed_at: 2023-06-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1816736/000119312523168460/0001193125-23-168460-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1816736/000119312523168460/d481795d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-168460
- JSON: https://secwatch.observer/filing/0001193125-23-168460.json
- Plain text: https://secwatch.observer/filing/0001193125-23-168460.txt

## Key facts
- Material Agreements
  Disc Medicine, Inc. entered into Underwriting Agreement with Morgan Stanley & Co. LLC, SVB Securities LLC, Stifel, Nicolaus & Company, Incorporated, BMO Capital Markets Corp. valued at $128.2 million net proceeds from public offering of common stock and pre-funded warrants (effective 2023-06-13).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: Morgan Stanley & Co. LLC, SVB Securities LLC, Stifel, Nicolaus & Company, Incorporated, BMO Capital Markets Corp.
  - Value: $128.2 million net proceeds from public offering of common stock and pre-funded warrants
  - Effective: 2023-06-13
  source text: On June 13, 2023, Disc Medicine, Inc. (the “Company”) entered into an Underwriting Agreement (the “Underwriting Agreement”) with Morgan Stanley & Co. LLC, SVB Securities LLC, Stifel, Nicolaus & Company, Incorporated, and BMO Capital Markets Corp., as representatives of the several underwriters listed on Schedule I thereto (the “Underwriters”), related to a public offering (the “Offering”) of (i) 2,595,919 shares of common stock of the Company, par value $0.0001 per share (“Common Stock”) at a price to the public of $49.00 per share and (ii) pre-funded warrants to purchase an aggregate of 204,081 shares of Common Stock (the “Pre-Funded Warrants”), at a price to the public of $48.9999 per Pre-Funded Warrant, which represents the per share public offering price for the Common Stock less the $0.0001 per share exercise price for each such Pre-Funded Warrant.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1816736/000119312523168460/0001193125-23-168460-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.